Big Gain For Mountain Crest Acquisition Corp. IV
Thu, Jan 04, 2024 at 07:47 PM
Mountain Crest Acquisition Corp. IV (MCAF:NASDAQ) rocketted at $12.76, representing a gain of 40.9%. On Thu, Jan 04, 2024, MCAF:NASDAQ touched a New 2-Week High of $12.76. From Fri, Dec 22, 2023, the stock recorded 60.00% Up Days and 50.00% Green Days
About Mountain Crest Acquisition Corp. IV (MCAF:NASDAQ)
Mountain Crest Acquisition Corp IV is a blank check company.
Top 10 Gainers:
- Omega Therapeutics Inc. (OMGA:NASDAQ), 94.69%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 94.49%
- KORE Group Holdings Inc. (KORE:NYSE), 60.53%
- Alaunos Therapeutics Inc Com (TCRT:NASDAQ), 56.21%
- Mobix Labs Inc. (MOBX:NASDAQ), 45.33%
- QuantumScape Corporation Class A (QS:NYSE), 43.08%
- Mountain Crest Acquisition Corp. IV (MCAF:NASDAQ), 40.94%
- Isoray. (DE) (CATX:NYSEMKT), 37.02%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 34.81%
- Top KingWin Ltd (TCJH:NASDAQ), 33.11%